Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: BRD 7389
  • Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao
Related CAS#:
376382-11-5 2351938-32-2
1423058-83-6 1482499-16-0
1357647-78-9 2109805-80-1
849234-64-6 1423058-85-8
1440209-96-0 1456542-69-0
1158522-08-7 940364-43-2
134104-43-1 131615-57-1
6906-52-1 930439-75-1
1018584-77-4 1375289-11-4
849349-65-1 127437-46-1

376382-11-5

376382-11-5 structure
376382-11-5 structure
  • Name: BRD-7389
  • Chemical Name: bas 05532738
  • CAS Number: 376382-11-5
  • Molecular Formula: C24H18N2O2
  • Molecular Weight: 366.41200
  • Catalog: Signaling Pathways MAPK/ERK Pathway Ribosomal S6 Kinase (RSK)
  • Create Date: 2016-07-01 07:04:20
  • Modify Date: 2024-08-10 13:33:21
  • BRD7389 is a specific RSK family kinase inhibitor with IC50s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1, RSK2, and RSK3, respectively. BRD7389 is a small-molecule inducer of insulin expression in pancreatic α-cells[1].
Name bas 05532738
Synonyms hms1493i11
Description BRD7389 is a specific RSK family kinase inhibitor with IC50s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1, RSK2, and RSK3, respectively. BRD7389 is a small-molecule inducer of insulin expression in pancreatic α-cells[1].
Related Catalog
Target

RSK1:1.5 μM (IC50)

RSK2:2.4 μM (IC50)

RSK3:1.2 μM (IC50)

CDK5/p35:6.5 μM (IC50)

DRAK1:2.8 μM (IC50)

FLT3:3.5 μM (IC50)

PIM1:3.7 μM (IC50)

PKG1α:6.5 μM (IC50)

SGK:13.8 μM (IC50)

In Vitro BRD7389 (0.425-6.8 μM) induces insulin expression in mouse α-cells after 3 days treatment. BRD7389 induces a dose-dependent up-regulation of insulin (Ins2) mRNA, peaking at 0.85 μM; 5 days treatment with BRD7389 results in greater induction of insulin gene expression, about 50-fold at 0.85 μM[1]. BRD7389 (0.85-6.8μM) significantly up-regulates Pdx1 mRNA expression in mouse α-cell line[1]. BRD7389 also increases β-cell-specific gene expression in primary human islet cells[1]. BRD7389 (1 μM; added 30 min prior to Carbachol treatment 48 h) fully abolishes carbachols timulated cell proliferation, but has little effect on the basal level of proliferation[2]. RT-PCR[1] Cell Line: Mouse α-cell line Concentration: 0.425, 0.85, 1.7, 3.4, 6.8 μM Incubation Time: 3 days and 5 days Result: Up-regulated expression of Pdx1. Cell Proliferation Assay[2] Cell Line: SNU-407 colon cancer cell Concentration: 1 μM Incubation Time: Added 30 min prior to Carbachol treatment (48 h) Result: Almost completely blocked Carbachol (1 mM)-stimulated cell proliferation.
References

[1]. Fomina-Yadlin D, et al. Small-molecule inducers of insulin expression in pancreatic alpha-cells. Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15099-104.

[2]. Park YS, et al. EGFR and PKC are involved in the activation of ERK1/2 and p90 RSK and the subsequent proliferation of SNU-407 colon cancer cells by muscarinic acetylcholine receptors. Mol Cell Biochem. 2012 Nov;370(1-2):191-8.
Molecular Formula C24H18N2O2
Molecular Weight 366.41200
Exact Mass 366.13700
PSA 62.22000
LogP 4.87940
Hazard Statements H413
RIDADR NONH for all modes of transport

Chemsrc provides CAS#:376382-11-5 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 376382-11-5 | Chemsrc address: https://m.chemsrc.com/en/baike/4302.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved